Market Watch-China-India and South east Asia ...

For the past two years I have observed that Top 30 Pharmaceutical companies are pumping heavily there cash in India, China and South east Asia region, Astra Zeneca has research centre in India for more than 15 years and in china like wise Novartis has one centre in Singapore for Malaria Research and has declared that it is going to pump around 1 Billion in China for establishment of its largest pharmaceutical research centre in Asia. Like wise Bristol Mayer Squibb had signed deal with Biocon last year and the Biopharma research group has started it's function in Bangalore this year and in Gurgaon where I have been working for sometime we have GSK Research centre and Merck clinical report division.....we can now think in the line that within 5 years Asia will be the hottest destination for Pharma and Biopharma research :)